Merck & Co.'s peptides could be undergoing a transformation into oral tablets thanks to a $493 million licensing deal the ...

Guggenheim analyst Vamil Divan maintained a Buy rating on Merck & Company (MRK – Research Report) today and set a price target of ...

In this article, we are going to take a look at where Merck & Co. Inc. (NYSE:MRK) stands against other high growth forever dividend stocks. Dividend stocks have trailed the broader market over the ...

Merck Merck (NYSE:MRK) is a healthcare company that manufactures pharmaceutical products to treat various conditions in many therapeutic areas, including cardiometabolic disease, c We recently ...

For some years industry observers have been asking what Merck & Co can do to reduce ... of the largest and most respected events for bio & pharmaceutical manufacturing professionals.

In October, Merck took up an option on the personalised RNA-based cancer vaccine with an upfront payment of $250 million as part of a collaboration first agreed in 2016 and expanded in 2018.

Hudson’s Bay, Canada’s oldest company, is seeking court permission to auction off its artifacts, art and even the royal charter that gave the business the power to dominate the 17th century ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

“We need to make semiconductors.” The investigation into pharmaceutical imports includes ingredients used to make such drugs and touches on many of the same aspects of relying on imports to ...